Neurologic clinical trial - 221AD035 (ENVISION)

Status:

Open/Enrolling

ClinicalTrials.gov:

 NCT05310071

221AD035 (ENVISION)

Drug

BIIB037

Phase

Phase IIIB/IV

Keywords

Alzheimer’s Disease | AD